TrialArthritis research & therapy2015

Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity.

Janet Pope et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.